Skip to content
ChickenStockChickenStock
ResearchSGMT
Sagimet Biosciences logo

Sagimet Biosciences (SGMT) stock

NASDAQ

$10.22-6.50%(-0.71)

As of the Nov 13, 2026 close (U.S. Eastern)

Events and reference metrics · 1

Compares the share price with the company's earnings, net assets and sales. Check trading status and financial notes separately.

Price date for the multiples · not confirmed · Financial period · Trailing twelve months

P/E and P/S use the latest four quarters where available · P/B uses the latest equity · Computed in-house by ChickenStock

P/E

-13.50x

Net loss — not comparable

P/B

3.01x

P/S

364.50x

Latest earnings

SEC filings

Jul–Sep 2026(FY2026 Q3)

Operating income decreased from the same period a year earlier.

Key reported figures come first. Select one to see the same quarter across three years.

See the same quarter across three years →

Filed Nov 12, 2026 · 10-Q · SEC EDGAR

Reported results are from SEC EDGAR filings. Reference information only, not investment advice.

Insider transactions

Recent Form 4 filings grouped by person, date and transaction type.

9 SEC filings
  • Kemble GeorgeDirector · Aug 14, 2026Open-market sale350,987 shares · $3.6M
    Avg. price $10.232862,161 shares held after
  • Kemble GeorgeDirector · Aug 14, 2026Option exercise350,987 shares · $2.2M
    Avg. price $6.36
    Show 2 price lots
    • 326,618 shares × $6.36$2.1M
    • 24,369 shares × $6.36$155K
  • Kemble GeorgeDirector · Aug 11, 2026Open-market sale20,206 shares · $201K
    Avg. price $9.954862,161 shares held after
  • Kemble GeorgeDirector · Aug 11, 2026Option exercise20,206 shares · $129K
    Avg. price $6.36
    Show 2 price lots
    • 10,455 shares × $6.36$66K
    • 9,751 shares × $6.36$62K
  • Happel DavidPresident & CEO · Jul 20, 2026Open-market sale64,051 shares · $497K
    Avg. price $7.7605741,570 shares held after
  • Kemble GeorgeDirector · Jul 20, 2026Open-market sale18,844 shares · $141K
    Avg. price $7.457562,161 shares held after
  • Rozek ElizabethChief Legal & Admin. Officer · Jul 20, 2026Open-market sale10,545 shares · $82K
    Avg. price $7.7603224,414 shares held after

Only transactions reported on SEC Form 4 are shown. A sale may follow a pre-arranged 10b5-1 plan, and items such as option exercises or shares withheld for taxes are not open-market trades.

Recent SEC filings

40 filings

Filings submitted to the U.S. Securities and Exchange Commission (EDGAR). Dates are SEC filing dates (U.S. Eastern). Form and item names are the official SEC titles. The Earnings and Risk tags come directly from form types and item codes; they are not written by AI. Insider ownership reports (Forms 3, 4 and 5) are excluded.

Company overview

Expand ▾

Sagimet Biosciences (SGMT) stock information

NASDAQ

Sagimet Biosciences (SGMT) is listed on NASDAQ. Its market capitalization is about $729M. On trailing-twelve-month earnings the P/E ratio is -13.5, and the P/B ratio is 3.01. Return on equity is -22.3%. These figures are computed in-house from official filings and are reference information only.

Sagimet Biosciences — frequently asked questions

What is the P/E ratio of Sagimet Biosciences (SGMT)?
On a trailing-twelve-month basis, SGMT trades at a P/E ratio of -13.5. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of Sagimet Biosciences?
SGMT has a market capitalization of about $729M. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, not a price forecast and not a recommendation to buy or sell. Investment decisions rest with the user.

All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.